[Federal Register Volume 62, Number 195 (Wednesday, October 8, 1997)]
[Proposed Rules]
[Page 52513]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-26641]
========================================================================
Proposed Rules
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains notices to the public of
the proposed issuance of rules and regulations. The purpose of these
notices is to give interested persons an opportunity to participate in
the rule making prior to the adoption of the final rules.
========================================================================
Federal Register / Vol. 62, No. 195 / Wednesday, October 8, 1997 /
Proposed Rules
[[Page 52513]]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
10 CFR Part 35
Medical Use of Byproduct Material; Workshop
AGENCY: Nuclear Regulatory Commission.
ACTION: Notice of workshop.
-----------------------------------------------------------------------
SUMMARY: The Nuclear Regulatory Commission has initiated a rulemaking
for a comprehensive revision to its regulations governing the medical
use of byproduct material in 10 CFR part 35. As part of this
rulemaking, the Commission intends to solicit the active input of the
various interests that may be affected by the rulemaking early in the
rulemaking process. One of the mechanisms that will be used to obtain
the comments and recommendations from affected interests will be the
convening of workshops to discuss the fundamental approaches and issues
that must be addressed in the revision of 10 CFR part 35. A workshop on
NRC's medical rulemaking initiative will be held during the
Organization of Agreement States' All Agreement States Meeting in Los
Angeles, California.
DATE: The workshop will be held on October 18, 1997, from 8:30 a.m. to
2:15 p.m.
ADDRESS: The Westin LAX Hotel, 5400 W. Century Blvd., Los Angeles, CA
90045.
FOR FURTHER INFORMATION CONTACT: Cathy Haney, U.S. Nuclear Regulatory
Commission, Office of Nuclear Material Safety and Safeguards, telephone
(301) 415-6825, e-mail cxh@nrc.gov.
SUPPLEMENTARY INFORMATION: The NRC has examined the issues
surrounding its medical use program in great detail during the last
four years. This process started with NRC's 1993 internal senior
management review report; continued with the 1996 independent
external review report by the National Academy of Sciences,
Institute of Medicine; and culminated in NRC's Strategic Assessment
and Rebaselining Project (SA). In particular, medical oversight was
addressed in the SA Direction-Setting Issue Paper Number 7 (DSI 7)
(released September 16, 1996). In its ``Staff Requirements
Memorandum (SRM)--COMSECY-96-057, Materials/Medical Oversight (DSI
7),'' dated March 20, 1997, the Commission directed the NRC staff
to revise Part 35, associated guidance documents, and, if
necessary, the Commission's 1979 ``Medical Policy Statement.'' The
Commission SRM specifically directed the restructuring of part 35
into a risk-informed, more performance-based regulation.
A June 30, 1997, SRM informed the NRC staff of the Commission's
approval, with comments, of the NRC staff's proposed program in SECY-
97-131, Supplemental Information on SECY-97-115, Program for Revision
of 10 CFR part 35, ``Medical Uses of Byproduct Material,'' and
Associated Federal Register Notice,'' dated June 20, 1997.
After Commission approval of the NRC staff's program to revise 10
CFR part 35 and associated guidance documents, the NRC staff initiated
the rulemaking process, as announced in 62 FR 42219 (August 6, 1997).
The rulemaking is being conducted using a group approach. A Working
Group and Steering Group consisting of representatives of NRC,
Organization of Agreement States(OAS), and Conference of Radiation
Control Program Directors have been established to develop rule text
alternatives, rule language, and associated guidance documents. State
participation in the process is intended to enhance development of
corresponding rules in State regulations, to provide an opportunity for
early State input, and to allow State staff to assess potential impacts
of NRC draft language on the regulation of non-Atomic Energy Act
materials used in medical diagnosis, treatment, or research, in the
States.
As directed by the Commission, the NRC staff has developed
alternatives, with draft regulatory text, for the more significant
issues associated with the regulation of the medical use of byproduct
material. These alternatives to regulation in specific areas are
intended to help focus the discussion during workshops and meetings
during the Fall of 1997 and to assist the NRC staff in developing the
text of the proposed rule. Alternative regulatory text has been
developed for: (a) The quality management program; (b) training and
experience for authorized users, radiation safety officers, and medical
physicists; (c) radiation safety committee; (d) patient notification of
reportable events; and (e) the threshold for reportable events. The
alternatives represent a broad range of possibilities and are being
provided to stimulate input from members of the public in an effort to
encourage all interested parties to provide input into the development
of the revised regulation. The staff has not selected any alternatives
at this time and is open to additional alternatives that might be
proposed, which are consistent with the guidance provided by the
Commission.
The OAS workshop will be open to the public, on a space available
basis. The agenda for the workshop will focus on discussion of the
above regulatory issues, but will also provide enough flexibility for
the public to have an opportunity to comment on related rulemaking
issues. Members of the public who are unable to attend the workshop can
obtain copies of the papers developed by the staff through NRC's Public
Document Room (U.S. Nuclear Regulatory Commission, Attention: NRC
Public Document Room, Washington, DC 20555-0001) or on the Internet via
NRC's Technical Conference Forum (http://techconf.llnl.gov/
noframe.html).
Dated at Rockville, Maryland this 2nd day of October, 1997.
For the Nuclear Regulatory Commission.
Donald A. Cool,
Director, Division of Industrial and Medical Nuclear Safety, Office of
Nuclear Material Safety and Safeguards.
[FR Doc. 97-26641 Filed 10-7-97; 8:45 am]
BILLING CODE 7590-01-P
